TriVascular Technologies (TRIV) Tops Q3 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts TRIV Hot Sheet
Join SI Premium – FREE
TriVascular Technologies (NASDAQ: TRIV) reported Q3 EPS of ($0.66), $0.05 better than the analyst estimate of ($0.71). Revenue for the quarter came in at $9.5 million versus the consensus estimate of $9.28 million.
Adjusted EBITDA, a non-GAAP measure, was a loss of $10.1 million for the third quarter of 2015 compared to $11.4 million in the third quarter of 2014.
For earnings history and earnings-related data on TriVascular Technologies (TRIV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- Uber Q3 profit, revenue beat estimates as gross bookings jump 20%
- Marriott International (MAR) PT Lowered to $141 at Jefferies
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
